Aplastic Anemia is a rare and serious blood disorder characterized by a failure of the bone marrow to produce an adequate number of blood cells. Stem cells in the bone marrow are damaged or suppressed, leading to low counts of red blood cells, white blood cells, and platelets. Common symptoms include fatigue, weakness, shortness of breath, pale skin, frequent infections, and easy bruising or bleeding. Diagnosis involves blood tests and a bone marrow biopsy to assess cell counts and identify potential causes. Treatment options include blood transfusions, medications to stimulate bone marrow function, and immunosuppressive therapy. In severe cases, a bone marrow transplant may be considered. Prognosis varies, and ongoing medical monitoring and supportive care are often necessary. Aplastic Anemia can be acquired or inherited, with acquired forms often idiopathic or associated with factors like drug exposure, toxins, infections, or autoimmune disorders. Managing this complex condition requires a multidisciplinary approach involving hematologists and other specialists.
Title : Knotless suture repair for chronic lateral ankle instability: A systematic review & single- arm meta-analysis
Hussein Jaber, University of Cambridge, United Kingdom
Title : The UK profemur recall and implant cobaltism
Stephen S Tower, University of Alaska Anchorage, United States
Title : The tomographic phenotype and the genotype of wormain bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Title : Total Knee Arthroplasty (TKA) in hemophilic arthropathy: Modern outcomes and perioperative strategies
Jack Russek, Touro University California, United States
Title : Musculoskeletal and orthopedic implications of Gender-Affirming Hormone Therapy (GAHT): A PRISMA-Guided systematic narrative review
Jack Russek, Touro University California, United States